Acute Management of Cardiac Complications in Pregnancy

Siamak Moayedi

DOI: https://doi.org/10.4172/2161-0932.1000245

2014-01-01

Abstract:Acute Management of Cardiac Complications in Pregnancy,<p>Siamak Moayedi</p>

What problem does this paper attempt to address?

Cardiovascular Complications in Pregnancy

Avisha Shah,Jay Patel,Ameesh Isath,Hafeez Ul Hassan Virk,Hani Jneid,Carolyn M. Zelop,Shilpi Mehta-Lee,Katherine E. Economy,Martha Gulati,Chayakrit Krittanawong

DOI: https://doi.org/10.1007/s11936-023-01000-8

2023-08-26

Current Treatment Options in Cardiovascular Medicine

Abstract:We review the epidemiology, risk factors, presentation, pathophysiology, diagnosis, peripartum management, and postpartum follow-up of chronic hypertension, hyperlipidemia, acute myocardial infarction, stroke, heart failure, pulmonary embolism, and atrial fibrillation.
Ischemic heart disease in pregnancy: a practical approach to management

Andrew H Nguyen,Ellen Murrin,Axucillia Moyo,Garima Sharma,Scott A Sullivan,George L Maxwell,Jamie L W Kennedy,Antonio F Saad

DOI: https://doi.org/10.1016/j.ajogmf.2024.101295

Abstract:Ischemic heart disease is a crucial issue during pregnancy. The term is composed of both preexisting conditions and acute coronary syndrome in pregnancy, including pregnancy-associated myocardial infarction, which can have a significant effect on maternal and fetal outcomes. This review provides a complete guide to managing ischemic heart disease in pregnant women, emphasizing the importance of multidisciplinary care and individualized treatment strategies. Cardiovascular disease, particularly ischemic heart disease, is now the leading cause of maternal mortality worldwide. Pregnancy introduces unique physiological changes that increase the risk of acute myocardial infarction, with pregnancy-associated myocardial infarction cases often associated with factors, such as advanced maternal age, chronic hypertension, and preexisting cardiovascular conditions. This review distinguishes between preexisting ischemic heart disease and pregnancy-associated myocardial infarction. It will emphasize the various etiologies of pregnancy-associated myocardial infarction, including coronary atherosclerosis and plaque rupture presenting as ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and other nonatherosclerotic causes, including spontaneous coronary artery dissection, vasospasm, and embolism. Our study discusses the practical management of ischemic heart disease in pregnancy, with a focus on preconception counseling, risk assessment, and tailored antenatal planning for women with preexisting ischemic heart disease. Moreover, this document focuses on the challenges of diagnosing cardiovascular disease, especially when presented with nonclassical risk factors and presentation. It provides insight into the appropriate diagnostic testing methods, such as electrocardiogram, cardiac biomarkers, and echocardiography. In addition, the review covers various treatment strategies, from medical management to more invasive procedures, including coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft. Special attention is given to medication safety during pregnancy, including anticoagulation, beta-blockers, and antiplatelet agents. The complexities of delivery planning in women with ischemic heart disease are discussed, advocating for a multidisciplinary team-based approach and careful consideration of the timing and mode of delivery. Furthermore, the roles of breastfeeding and postpartum care are explored, emphasizing the long-term benefits and the suitability of various medications during lactation. Lastly, this review provides crucial insights into the management of ischemic heart disease in pregnancy, stressing the need for heightened awareness, prompt diagnosis, and tailored management to optimize maternal and fetal health outcomes.
Caring for two in the ICU: Pharmacologic management of pregnancy-related complications

Mojdeh S Heavner,Michaelia D Cucci,Brooke Barlow,Carolyn Magee Bell,Claire C Eng,Grace Erdman,Matthew Li,Susan E Smith,Mohammed Aldhaeefi,Melissa L Thompson Bastin,W Anthony Hawkins,Christina Rose,Allison Lankford

DOI: https://doi.org/10.1002/phar.2837

Pharmacotherapy

Abstract:Maternal mortality continues to be an issue globally despite advances in technology and pharmacotherapy. Pregnancy can lead to complications that necessitate immediate action to prevent severe morbidity and mortality. Patients may need escalation to the ICU setting for close monitoring and administration of advanced therapies not available elsewhere. Obstetric emergencies are rare but high-stakes events that require clinicians to have prompt identification and management. The purpose of this review is to describe complications of pregnancy and provide a focused resource of pharmacotherapy considerations that clinicians may encounter. For each disease state, the epidemiology, pathophysiology, and management are summarized. Brief descriptions of non-pharmacological (e.g., cesarean or vaginal delivery of the baby) interventions are provided. Mainstays of pharmacotherapy highlighted include oxytocin for obstetric hemorrhage, methotrexate for ectopic pregnancy, magnesium and antihypertensive agents for preeclampsia and eclampsia, eculizumab for atypical hemolytic uremic syndrome, corticosteroids, and immunosuppressive agents for thrombotic thrombocytopenic purpura, diuretics, metoprolol, and anticoagulation for peripartum cardiomyopathy, and pulmonary vasodilators for amniotic fluid embolism.
Acute Myocardial Infarction in Pregnancy

Jitae A Kim,Sophie Y Kim,Hafeez Ul Hassan Virk,Mahboob Alam,Samin Sharma,Mark R Johnson,Chayakrit Krittanawong,Jitae A. Kim,Sophie Y. Kim,Mark R. Johnson

DOI: https://doi.org/10.1097/crd.0000000000000681

2024-02-27

Cardiology in Review

Abstract:Pregnancy-associated myocardial infarction is an overall uncommon event, but can be associated with significant maternal and fetal morbidity and mortality. In contrast to myocardial infarction in the general nonpregnant population, the mechanism of pregnancy-associated myocardial infarction is most commonly due to nonatherosclerotic mechanisms such as coronary dissection, vasospasm, or thromboembolism. The diagnosis of pregnancy-associated myocardial infarction can be challenging, requiring a high index of suspicion for prompt recognition and management. Furthermore, the management of pregnancy-associated myocardial infarction can be complex due to maternal and fetal considerations and may vary based on the specific underlying mechanism of the myocardial infarction. This review aims to review the recent literature on pregnancy-associated myocardial infarction and summarize the epidemiology, mechanisms, diagnosis, and treatment strategies for this uncommon entity.

cardiac & cardiovascular systems
Perioperative Management of Acute Myocardial Infarction in the 31st Week of Pregnancy: A Case Report and Literature Review

Pei Sun,Xinmiao Liang,Tzung-Pei Hong,Hong Zhang

DOI: https://doi.org/10.3389/fsurg.2022.1023551

IF: 1.8

2022-01-01

Frontiers in Surgery

Abstract:Pregnancy-related acute myocardial infarction (PAMI) is rare but life-threatening. The incidence of PAMI is growing over time for multiple reasons, and the management of parturients with acute myocardial infarction is challenging in terms of diagnosis and treatment. To date, there are still no clear guidelines on the best practice for PAMI. We present a case of a 41-year-old woman with PAMI at 31 weeks of pregnancy. Through multidisciplinary collaboration, successful outcomes were achieved for both the mother and fetus.
Management in the Emergency Department and Critical Care

Elena Conti,Nunzio Dario Cascio,Patrizia Paluan,Giulia Racca,Yaroslava Longhitano,Gabriele Savioli,Manfredi Tesauro,Roberto Leo,Fabrizio Racca,Christian Zanza

DOI: https://doi.org/10.3390/jcm13041095

IF: 3.9

2024-02-16

Journal of Clinical Medicine

Abstract:Pregnancy is closely associated with an elevated risk of arrhythmias, constituting the predominant cardiovascular complication during this period. Pregnancy may induce the exacerbation of previously controlled arrhythmias and, in some instances, arrhythmias may present for the first time in pregnancy. The most important proarrhythmic mechanisms during pregnancy are the atrial and ventricular stretching, coupled with increased sympathetic activity. Notably, arrhythmias, particularly those originating in the ventricles, heighten the likelihood of syncope, increasing the potential for sudden cardiac death. The effective management of arrhythmias during the peripartum period requires a comprehensive, multidisciplinary approach from the prepartum to the postpartum period. The administration of antiarrhythmic drugs during pregnancy necessitates meticulous attention to potential alterations in pharmacokinetics attributable to maternal physiological changes, as well as the potential for fetal adverse effects. Electric cardioversion is a safe and effective intervention during pregnancy and should be performed immediately in patients with hemodynamic instability. This review discusses the pathophysiology of arrythmias in pregnancy and their management.

medicine, general & internal
EP12.13: Instigating multi‐professional management of pregnant women with cardiac disease

R. Parasuraman,L. Stocker,L. Relton,P. Mackie,E. Jolly,S. Fitzsimmons,A. Carroll

DOI: https://doi.org/10.1002/uog.28565

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 240-240, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Maternal heart failure: state-of-the-art review

Usman S. Najam,Jitae A. Kim,Sophie Y. Kim,Gurleen Wander,Mario Rodriguez,Hafeez Ul Hassan Virk,Mark R. Johnson,W. H. Wilson Tang,Chayakrit Krittanawong

DOI: https://doi.org/10.1007/s10741-024-10466-y

2024-11-16

Heart Failure Reviews

Abstract:Pregnancy is a period of substantial changes to the body's normal physiology, and the failure to adapt to these changes can lead to life-threatening pathology, particularly involving the cardiovascular system. In comparison to pre-pregnancy physiology, pregnant women have increased blood volume and physical demands which exert increased stress on the heart. This is important to consider in women with and without previously diagnosed cardiovascular disease, as the physiologic changes during pregnancy and postpartum can lead to sudden decompensation. The management of heart failure is particularly important as it remains the most common cardiovascular complication during pregnancy and is associated with substantial maternal and fetal morbidity and mortality. This is especially true in patients with pre-existing heart failure, who should receive counseling before conception and in certain cases be advised against pregnancy. For these reasons, healthcare professionals must be well-versed in the different strategies of diagnosis, management, treatment, and monitoring. This review will outline the pathophysiology, diagnostics, management, and general approach to heart failure in pregnant patients.

cardiac & cardiovascular systems
Cardiovascular complications during pregnancy: Advancing cardio-obstetrics

Sneha Annie Sebastian,Yashendra Sethi,Arpita Mariam Mathews,Tony Santhosh,Edzel Lorraine Co,Inderbir Padda,Gurpreet Johal

DOI: https://doi.org/10.1016/j.disamonth.2024.101780

IF: 4.477

2024-06-25

Disease-a-Month

Abstract:As the incidence of cardiovascular diseases (CVDs) continues to rise among women of childbearing age, the pregnant population with pre-existing heart conditions presents a complex and heterogeneous profile. These women face varying degrees of risk concerning maternal cardiovascular, obstetric, and fetal complications. Effectively managing adverse cardiovascular events during pregnancy presents substantial clinical challenges. The uncertainties surrounding diagnostic and therapeutic approaches create a dynamic landscape with potential implications for maternal and fetal health. Cardio-obstetrics has become increasingly recognized as a vital multidisciplinary field necessitating a collaborative approach to managing cardiovascular conditions during pregnancy. In this review, we aim to provide a thorough and up-to-date examination of the existing evidence, offering a comprehensive overview of strategies and considerations in the management of cardiovascular complications during pregnancy. Special emphasis is placed on the safety assessment of diagnostic procedures and the exploration of treatment options designed to prioritize the well-being of the mother and fetus. We also explore the significance of a multidisciplinary cardio-obstetrics team in providing comprehensive care for women of childbearing age with or at risk for CVD.

medicine, general & internal
Peripartum management of cardiac arrhythmias: a narrative review

Andrew K Hallmark,Kathryn J Lindley,Jennifer M Banayan

DOI: https://doi.org/10.1016/j.ijoa.2024.104243

2024-08-02

Abstract:Cardiac arrhythmias are responsible for a significant portion of cardiovascular disease among pregnant people. As the incidence of arrhythmias in pregnancy continues to increase, anesthesiologists who care for obstetric patients should be experts managing arrhythmias in pregnancy. This article examines the most common arrhythmias encountered in pregnancy, including risk factors, diagnosis, and management strategies. Peripartum monitoring and labor analgesia recommendations are discussed. Additionally, management of cardioversion, management of pacemakers and implantable cardioverter-defibrillators, and advanced cardiac life support in the setting of pregnancy is reviewed.
[Internal medical emergencies in the pregnant patient : Peripartum sepsis, metabolic derailment, endocrinological emergencies and pulmonary edema]

J Fischer,G Gerresheim,U Schwemmer

DOI: https://doi.org/10.1007/s00063-022-00910-y

Abstract:Peripartum emergencies that require intensive medical care represent a major challenge for the interdisciplinary treatment team. Due to physiological changes in pregnant women symptoms can be masked and the initiation of treatment is delayed. Peripartum sepsis has a relatively high incidence. The anti-infective treatment depends on the spectrum of pathogens to be expected. Endocrinological emergencies are rare but can be fulminant and fatal. The development of ketoacidosis is favored by decreased bicarbonate buffer and placental hormones. In the case of thyrotoxicosis, propylthiouracil and thiamazole are available for treatment depending on the stage of gestation. Sheehan's syndrome is an infarction of the anterior lobe of the pituitary gland during a hemorrhage. Due to the loss of production of vital hormones, this can be fatal. The development of pulmonary edema is just as acute. This is favored by physiological changes during pregnancy. The differentiation between hypertensive and hypotensive pulmonary edema is important for the causal treatment.
Critical care management of pulmonary arterial hypertension in pregnancy: the pre-, peri- and post-partum stages

Vorakamol Phoophiboon,Monvasi Pachinburavan,Nicha Ruamsap,Natthawan Sanguanwong,Nattapong Jaimchariyatam

DOI: https://doi.org/10.4266/acc.2021.00458

2021-11-30

Acute and Critical Care

Abstract:The mortality rate of pulmonary hypertension in pregnancy is 25%–56%. Pulmonary arterial hypertension is the highest incidence among this group, especially in young women. Despite clear recommendation of pregnancy avoidance, certain groups of patients are initially diagnosed during the gestational age step into the third trimester. While the presence of right ventricular failure in early gestation is usually trivial, it can be more severe in the late trimester. Current evidence shows no consensus in the management and serious precautions for each stage of the pre-, peri- and post-partum periods of this specific group. Pulmonary hypertension-targeted drugs, mode of delivery, type of anesthesia, and some avoidances should be planned among a multidisciplinary team to enhance maternal and fetal survival opportunities. Sudden circulatory collapse from cardiac decompensation during the peri- and post-partum phases is detrimental, and mechanical support such as extracorporeal membrane oxygenation should be considered for mitigating hemodynamics and extending cardiac recovery time. Our review aims to explain the pathophysiology of pulmonary arterial hypertension and summarize the current evidence for critical management and precautions in each stage of pregnancy.
Cardiac medications in obstetric patients

Stephanie M Spehar,Emma Albert-Stone,Melinda B Davis

DOI: https://doi.org/10.1097/HCO.0000000000001039

2023-05-01

Abstract:Purpose of review: This review summarizes recent literature, updated safety data, and major clinical considerations for commonly used medications for arrhythmias, heart failure, hypertension, ischemic heart disease, and anticoagulation during pregnancy and lactation. Recent findings: Recent studies have shown a benefit to more aggressive treatment of mild chronic hypertension to a blood pressure goal of <140/90 with oral labetalol and nifedipine remaining first-line agents. Aspirin is now routinely used for preeclampsia prevention, while experience with other antiplatelet agents, such as purinergic receptor P2Y G protein-coupled 12 (P2Y12) inhibitors, continues to grow. Data on statin therapy are rapidly changing and recent studies suggest this class may not be associated with fetal harm and can be continued in select cases. Summary: As data regarding medication safety continues to evolve, a multidisciplinary team is needed for full consideration of maternal and fetal risks and benefits. Ongoing studies are needed to improve and expand our understanding of medication safety during pregnancy and lactation.
Cardiac physiology and pathophysiology in pregnancy

Shekoofeh Saboktakin Rizi,Evan Wiens,Jennifer Hunt,Robin Ducas

DOI: https://doi.org/10.1139/cjpp-2024-0010

2024-08-31

Canadian Journal of Physiology and Pharmacology

Abstract:Canadian Journal of Physiology and Pharmacology, Ahead of Print. Cardiovascular disease is the leading indirect cause of maternal morbidity and mortality, accounting for nearly one third of maternal deaths during pregnancy. The burden of cardiovascular disease in pregnancy is increasing, as are the incidence of maternal morbidity and mortality. Normal physiologic adaptations to pregnancy, including increased cardiac output and plasma volume, may unmask cardiac conditions, exacerbate previously existing conditions, or create de novo complications. It is important for care providers to understand the normal physiologic changes of pregnancy and how they may impact the care of patients with cardiovascular disease. This review outlines the physiologic adaptions during pregnancy and their pathologic implications for some of the more common cardiovascular conditions in pregnancy.

pharmacology & pharmacy,physiology
EP12.10: Cardiac disease in pregnancy and perinatal outcomes

R.A. Al Thobaiti,I. Babic

DOI: https://doi.org/10.1002/uog.28562

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 239-239, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Managing hepatic complications of pregnancy: practical strategies for clinicians

Maura Alice Morrison,Yooyun Chung,Michael A Heneghan

DOI: https://doi.org/10.1136/bmjgast-2021-000624

2022-03-01

BMJ Open Gastroenterology

Abstract:Liver disorders specific to pregnancy are rare but can have potentially serious consequences for mother and fetus. Pregnancy-related liver disorders are the most common cause of liver disease in otherwise healthy pregnant women and pose a challenge to physicians because of the need to take into account both maternal and fetal health. A good knowledge of these disorders is necessary as prompt diagnosis and appropriate management results in improved maternal and fetal outcomes. This review will focus on pregnancy-specific disorders and will aim to serve as a guide for physicians in their diagnosis, management and subsequent monitoring.
A Practical Approach to the Diagnosis and Initial Management of Acute Right Ventricular Failure during Pregnancy using Point-of-Care Ultrasound

Juliana Gevaerd Martins,Antonio Saad,George Saade,Luis D Pacheco

DOI: https://doi.org/10.1016/j.ajogmf.2024.101517

2024-10-09

Abstract:Acute right ventricular failure is a critical condition in pregnancy that can lead to severe maternal and fetal complications. This expert review discusses the instrumental role of Point-of-Care Ultrasound in diagnosing and managing ARVF in pregnant patients, highlighting its benefits for immediate clinical decision-making in obstetric emergencies. The unique physiological changes during pregnancy, such as increased blood volume and cardiac output, can exacerbate underlying or latent cardiac issues, making pregnant patients particularly susceptible to acute right ventricular failure. Common causes during pregnancy include pulmonary embolism, peripartum cardiomyopathy, and congenital heart diseases, each presenting distinct challenges in diagnosis and management. The real-time capability of point-of-care ultrasound allows for the immediate assessment of right ventricular size and function, evaluation of fluid status via the inferior vena cava, and identification of potential pulmonary embolism, offering a non-invasive, rapid, and dynamic diagnostic tool right at the bedside. The expert review details specific point-of-care ultrasound techniques adapted for pregnant patients, including the parasternal long and short axis and apical four-chamber view, essential for evaluating right heart function and guiding acute management strategies. These include fluid management, adjustment of pharmacological treatment, and immediate interventions to support cardiac function and reduce ventricular overload. Point-of-care ultrasound enhances clinical outcomes by allowing clinicians to make informed decisions quickly, reducing the time to intervention, and tailoring management strategies to individual patient needs. However, despite its apparent advantages, the adoption of point-of-care ultrasound requires specialized training and familiarity with obstetric-specific protocols. This review advocates for the integration of point-of-care ultrasound into standard obstetric care protocols, emphasizing the need for clear guidelines and structured protocols that equip healthcare providers with the skills necessary to utilize this technology effectively. Future research should aim to refine these protocols and expand the evidence base to solidify the role of point-of-care ultrasound in improving maternal and fetal outcomes in acute right ventricular failure.
Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020)

Danish Iltaf Satti,Eunjung Choi,Harsh P Patel,Mohammed Faisaluddin,Adhya Mehta,Bhavin Patel,Chigolum Pamela Oyeka,Shruti Hegde,Yaa Adoma Kwapong,Jeffrey Shi Kai Chan,Shannon Anderson,Nasrien E Ibrahim,Shashank S Sinha,Sourbha S Dani,Garima Sharma

DOI: https://doi.org/10.1016/j.cpcardiol.2024.102855

Abstract:Background: Cardiomyopathy (CDM) in pregnancy is associated with maternal morbidity and mortality. Objectives: To explore trends and clinical outcomes in CDM subtypes during delivery hospitalizations. Methods: We used the National Inpatient Sample database to identify delivery hospitalizations between 2005-2020 by CDM subtypes: peripartum (PPCM), dilated (DCM), hypertrophic (HCM), and restrictive (RCM). Maternal and fetal outcomes were identified using International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes. Baseline characteristics and temporal trends of CDM subtypes were analyzed. Maternal cardiovascular, pregnancy, and fetal outcomes were evaluated by CDM subtype using univariate logistic regression. The primary outcome was in-hospital mortality. Results: During 2005-2020, 37,125 out of 61,811,842 delivery hospitalizations were complicated by CDM. Among CDM-related delivery hospitalizations, the most prevalent were DCM (46%), followed by PPCM (45.6%), HCM (4.6%), and RCM (3.9%). The rates of in-hospital mortality (1.7%), adverse cardiovascular events such as acute heart failure (17%), cardiogenic shock (3.4%), and cardiac arrest (3.1%), and adverse pregnancy outcomes such as preeclampsia (14.2%) and preterm labor (11%), were highest among PPCM (all p < 0.0001). The prevalence of PPCM (49.1% to 38.5%) decreased while the prevalence of HCM (2.7% to 8.8%) and DCM (48% to 52.2%) increased over time. Conclusions: Over a 15-year period, PPCM had higher rates of in-hospital mortality, cardiovascular events, and adverse pregnancy outcomes compared to other CDM subtypes. While the prevalence of PPCM decreased over time, the prevalence of HCM and DCM increased. Hence, further research on cardiomyopathies during pregnancy and prospective studies on this vulnerable patient cohort are urgently needed.
Endocrine Emergencies in Obstetrics

Christopher G Goodier

DOI: https://doi.org/10.1097/GRF.0000000000000433

Abstract:Endocrine emergencies in pregnancy can be life threatening and are associated with increased morbidity for both the mother and fetus. Thyroid storm, diabetic ketoacidosis, and hypercalcemic crisis require a high clinical suspicion, rapid treatment, and multidisciplinary care to ensure best outcomes. Critical care consultation and intensive care unit admission are often warranted. Fetal testing may initially be concerning; however often improves with correction of the underlying metabolic derangement(s) and delivery is generally avoided until maternal status improves.
Prevention and treatment of cardiovascular diseases induced by hypertensive disorders of pregnancy

Guo-jun MA,Jian-hua LIN

DOI: https://doi.org/10.19538/j.fk2018050112

2018-01-01

Abstract:Cardiovascular diseases induced by hypertensive disorders of pregnancy is a cardiac pump dysfunction that occurs on the basis of hypertensive disorders in pregnancy.In severe cases,there is even a group of heart failure syndromes characterized by left heart failure.The disease is extremely dangerous and has a high lethality.However,the disease often onsets occultly because its early symptoms are easily overlooked.Therefore,patients with hypertensive disorders complicating pregnancy should receive efficient antihypertensive treatments as well as dynamical heart function evaluation.In addition,active correction of high risk factors contributes to the prevention of heart failure.For patients who have had acute heart failure, besides the treatment for acute heart failure,it is also significant to take appropriate measures to treat the primary disease of preeclampsia and terminate the pregnancy in time.

Acute Management of Cardiac Complications in Pregnancy

Cardiovascular Complications in Pregnancy

Ischemic heart disease in pregnancy: a practical approach to management

Caring for two in the ICU: Pharmacologic management of pregnancy-related complications

Acute Myocardial Infarction in Pregnancy

Perioperative Management of Acute Myocardial Infarction in the 31st Week of Pregnancy: A Case Report and Literature Review

Management in the Emergency Department and Critical Care

EP12.13: Instigating multi‐professional management of pregnant women with cardiac disease

Maternal heart failure: state-of-the-art review

Cardiovascular complications during pregnancy: Advancing cardio-obstetrics

Peripartum management of cardiac arrhythmias: a narrative review

[Internal medical emergencies in the pregnant patient : Peripartum sepsis, metabolic derailment, endocrinological emergencies and pulmonary edema]

Critical care management of pulmonary arterial hypertension in pregnancy: the pre-, peri- and post-partum stages

Cardiac medications in obstetric patients

Cardiac physiology and pathophysiology in pregnancy

EP12.10: Cardiac disease in pregnancy and perinatal outcomes

Managing hepatic complications of pregnancy: practical strategies for clinicians

A Practical Approach to the Diagnosis and Initial Management of Acute Right Ventricular Failure during Pregnancy using Point-of-Care Ultrasound

Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020)

Endocrine Emergencies in Obstetrics

Prevention and treatment of cardiovascular diseases induced by hypertensive disorders of pregnancy